(Reuters) – China’s WuXi AppTec said on Tuesday its subsidiaries have signed a deal with U.S.-based private equity firm Altaris LLC for the sale of its cell and gene therapy manufacturing unit, WuXi Advanced Therapies, for an undisclosed sum.
(Reporting by Rajasik Mukherjee; Editing by Krishna Chandra Eluri)
Disclaimer: This report is auto generated from the Reuters news service. ThePrint holds no responsibility for its content.
source: https://theprint.in/tech/chinas-wuxi-to-sell-advanced-therapies-unit-to-us-private-equity-firm/2417923/
